Last reviewed · How we verify

NCT06242886: OM

After Caesarean Section Oxitocin Breast Massage Anthropometric Characteristics of the Newborn

Completed NA Last updated 5 February 2024
What this trial tests

NA trial testing Oxytocin massage in Breastfeeding, Exclusive in 42 participants. Completed in 20 September 2023.

Timeline
20 February 2023
Primary endpoint
20 August 2023
20 September 2023

Quick facts

Lead sponsorHalic University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment42
Start date20 February 2023
Primary completion20 August 2023
Estimated completion20 September 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Halic University

Who can join

Adults 18 to 35, female only, with Breastfeeding, Exclusive or Breastfeeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Delays in breastfeeding and milk release after cesarean section may negatively affect the early initiation of breastfeeding and the mother's breastfeeding self-efficacy. Research Aims: The aim of this study was to investigate the effect of breast and oxytocin massage after cesarean section on the anthropometric characteristics of the newborn and breastfeeding self-efficacy. Methods: The study was conducted in a single-blind randomized controlled type and 126 mothers who delivered by cesarean section in the postpartum department of a private hospital in Istanbul/Turkey were randomized into three groups as 42 breast massage, 42 oxytocin massage and 42 control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breastfeeding, Exclusive

Currently open trials in the same condition.

Other Halic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06242886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing